Abstract
Terbutaline, a new bronchodilator acting on β-adrenergic receptors, was given to 10 asthmatic patients, who received on separate days 5 mg orally, 10 mg orally, and 0·25 mg subcutaneously. The ventilatory response was assessed by measurement of the FEV1 before and at intervals after administration. The cardiovascular response was assessed by measurement of the heart rate and blood pressure and by electrocardiography at the same times as spirometry was performed.
The ventilatory response to all three doses and by both routes was satisfactory. The maximal increase in FEV1 after 5 mg orally was only slightly less than that after 10 mg. The maximal increase in heart rate after 5 mg orally was about half that which occurred after 10 mg. It is concluded that 5 mg orally and 0·25 mg subcutaneously are suitable doses.
In general a modest fall in blood pressure affected the diastolic more than the systolic. On E.C.G. the T wave was often depressed, and in one patient, it was inverted. A trough-like depression of the QRS baseline occurred several times. The significance of the E.C.G. changes is uncertain.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bergman J., Persson H., Wetterlin K. 2 new groups of selective stimulants of adrenergic beta-receptors. Experientia. 1969 Sep 15;25(9):899–901. doi: 10.1007/BF01898049. [DOI] [PubMed] [Google Scholar]
- Formgren H. Clinical comparison of inhaled terbutaline and orciprenaline in asthmatic patients. Scand J Respir Dis. 1970;51(3):203–211. [PubMed] [Google Scholar]
- LITTMAN A., GROSSMAN M. I., GUNNAR R. M., ISAACS J. H., HIRSCHMANN J. H., FOLEY E. F. Electrocardiographic effects of arterenol and isopropylarterenol in man, with a note on the auricular T wave. J Appl Physiol. 1950 Nov;3(5):235–242. doi: 10.1152/jappl.1950.3.5.235. [DOI] [PubMed] [Google Scholar]
- Lands A. M., Arnold A., McAuliff J. P., Luduena F. P., Brown T. G., Jr Differentiation of receptor systems activated by sympathomimetic amines. Nature. 1967 May 6;214(5088):597–598. doi: 10.1038/214597a0. [DOI] [PubMed] [Google Scholar]
- Mattila M. J., Muittari A. Effect of bronchodilator drugs on the peak expiratory flow rate of asthmatic patients: oral orciprenaline and terbutaline (KWD 2019). Ann Med Exp Biol Fenn. 1969;47(4):298–302. [PubMed] [Google Scholar]
- Riding W. D., Dinda P., Chatterjee S. S. The bronchodilator and cardiac effects of five pressure-packed aerosols in asthma. Br J Dis Chest. 1970 Jan;64(1):37–45. doi: 10.1016/s0007-0971(70)80047-x. [DOI] [PubMed] [Google Scholar]